4:59 PM ET
8-K
Reverse Stock Split
Impact Biomedical Reverse Stock Split
Impact BioMedical Inc. implemented a 1-for-12.62 reverse stock split of its common stock effective September 23, 2026. The split reduced the number of outstanding shares from approximately 107.8 million to 8.6 million to adjust the company's capital structure. The stock began trading on a split-adjusted basis on the NYSE American under the existing ticker symbol 'IBO'.